Pablo Restrepo, PA
Surgical · Baltimore, MDNPI 1487139424
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $896 of the $1,034 with a category attached, or 86.7%. 9 manufacturers reported payments, led by Johnson & Johnson at 35.2% of the total. 2025 is the largest year on record at $407, more than ten times the $21 reported in 2021.
Across 21 payments — averaging $49.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$364
- Medical Device Business Services, Inc.$204
- Stryker$189
- Davol Inc.$121
- Kls-martin L.p.$69
- Integra Lifesciences Corporation$32
- plus $55 from 3 others
What the payments were for
- Travel & lodging$13813%
- Food & beverage$89687%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $364 |
| Medical Device Business Services, Inc. | 4 | $204 |
| Stryker | 2 | $189 |
| Davol Inc. | 1 | $121 |
| Kls-martin L.p. | 1 | $69 |
| Integra Lifesciences Corporation | 1 | $32 |
| GRT US Holding, Inc. | 1 | $21 |
| Silk Road Medical, Inc. | 1 | $20 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPY-PHI SYSTEM$173
- STRATAFIX$138
- Phasix Mesh$121
How this compares
$1,034 in reported general payments places this provider in the 80th percentile of 277 surgical providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 185 | $1,034 |
| Mupirocin | 26 | $163 |
| Oxycodone Hcl | 24 | $91 |
| Pregabalin | 35 | $83 |
| Cephalexin | 15 | $17 |
| Amoxicillin | 16 | $13 |
Paid to pharmacies, not to this prescriber.
Other surgical in Baltimore
- Erika NigamBaltimore$8K
- Tara MorrisBaltimore$7K
- Simone BeattieBaltimore$7K
- Cairo KeenanBaltimore$4K
- Rakhmin KhoshayevBaltimore$4K
- Olga Duclos-LasnierBaltimore$4K
- Rashel CastelgrandeBaltimore$3K
- Samantha HammockBaltimore$2K
- Nam PhamBaltimore$2K
- Lindsey ManosBaltimore$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.